Literature DB >> 32609012

Upregulation of CD32 in T Cells from Infants with Severe Respiratory Syncytial Virus Disease: A New Costimulatory Pathway?

Inés Sananez1,2, Silvina Raiden2,3, María P Holgado1,2, Vanesa Seery1,2, Leonardo De Lillo3, Carolina Davenport3, Fernando Ferrero3, Mark E Peeples4, Jorge Geffner1,2, Lourdes Arruvito1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32609012      PMCID： PMC7710334          DOI： 10.1165/rcmb.2020-0025LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  12 in total

Review 1.  Type I and type II Fc receptors regulate innate and adaptive immunity.

Authors:  Andrew Pincetic; Stylianos Bournazos; David J DiLillo; Jad Maamary; Taia T Wang; Rony Dahan; Benjamin-Maximillian Fiebiger; Jeffrey V Ravetch
Journal:  Nat Immunol       Date:  2014-08       Impact factor: 25.606

Review 2.  Complement system in lung disease.

Authors:  Pankita H Pandya; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

3.  CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Authors:  Mohamed Abdel-Mohsen; Leticia Kuri-Cervantes; Judith Grau-Exposito; Adam M Spivak; Racheal A Nell; Costin Tomescu; Surya Kumari Vadrevu; Leila B Giron; Carla Serra-Peinado; Meritxell Genescà; Josep Castellví; Guoxin Wu; Perla M Del Rio Estrada; Mauricio González-Navarro; Kenneth Lynn; Colin T King; Sai Vemula; Kara Cox; Yanmin Wan; Qingsheng Li; Karam Mounzer; Jay Kostman; Ian Frank; Mirko Paiardini; Daria Hazuda; Gustavo Reyes-Terán; Douglas Richman; Bonnie Howell; Pablo Tebas; Javier Martinez-Picado; Vicente Planelles; Maria J Buzon; Michael R Betts; Luis J Montaner
Journal:  Sci Transl Med       Date:  2018-04-18       Impact factor: 17.956

4.  Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.

Authors:  Junyan Han; Katsuyuki Takeda; Meiqin Wang; Wanjiang Zeng; Yi Jia; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

5.  Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors.

Authors:  Sarah Geoghegan; Anabella Erviti; Mauricio T Caballero; Fernando Vallone; Stella M Zanone; Juan Ves Losada; Alejandra Bianchi; Patricio L Acosta; Laura B Talarico; Adrian Ferretti; Luciano Alva Grimaldi; Andrea Sancilio; Karina Dueñas; Gustavo Sastre; Andrea Rodriguez; Fernando Ferrero; Edgar Barboza; Guadalupe Fernández Gago; Celina Nocito; Edgardo Flamenco; Alberto Rodriguez Perez; Beatriz Rebec; F Martin Ferolla; Romina Libster; Ruth A Karron; Eduardo Bergel; Fernando P Polack
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

6.  Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.

Authors:  Cristina Capella; Supranee Chaiwatpongsakorn; Erin Gorrell; Zachary A Risch; Fang Ye; Sara E Mertz; Sara M Johnson; Melissa Moore-Clingenpeel; Octavio Ramilo; Asuncion Mejias; Mark E Peeples
Journal:  J Infect Dis       Date:  2017-12-12       Impact factor: 5.226

7.  CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.

Authors:  John P Thornhill; Matthew Pace; Genevieve E Martin; Jonathan Hoare; Simon Peake; Carolina Herrera; Chan Phetsouphanh; Jodi Meyerowitz; Emily Hopkins; Helen Brown; Polly Dunn; Natalia Olejniczak; Christian Willberg; Paul Klenerman; Rob Goldin; Julie Fox; Sarah Fidler; John Frater
Journal:  Mucosal Immunol       Date:  2019-06-25       Impact factor: 7.313

Review 8.  The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

Authors:  Natalie I Mazur; Deborah Higgins; Marta C Nunes; José A Melero; Annefleur C Langedijk; Nicole Horsley; Ursula J Buchholz; Peter J Openshaw; Jason S McLellan; Janet A Englund; Asuncion Mejias; Ruth A Karron; Eric Af Simões; Ivana Knezevic; Octavio Ramilo; Pedro A Piedra; Helen Y Chu; Ann R Falsey; Harish Nair; Leyla Kragten-Tabatabaie; Anne Greenough; Eugenio Baraldi; Nikolaos G Papadopoulos; Johan Vekemans; Fernando P Polack; Mair Powell; Ashish Satav; Edward E Walsh; Renato T Stein; Barney S Graham; Louis J Bont
Journal:  Lancet Infect Dis       Date:  2018-06-18       Impact factor: 25.071

9.  CD32 Ligation Promotes the Activation of CD4+ T Cells.

Authors:  María Pía Holgado; Inés Sananez; Silvina Raiden; Jorge R Geffner; Lourdes Arruvito
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

Review 10.  Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors.

Authors:  Anil K Chauhan
Journal:  Front Immunol       Date:  2016-06-01       Impact factor: 7.561
View more
  3 in total

Review 1.  Update in Critical Care 2020.

Authors:  Robinder G Khemani; Jessica T Lee; David Wu; Edward J Schenck; Margaret M Hayes; Patricia A Kritek; Gökhan M Mutlu; Hayley B Gershengorn; Rémi Coudroy
Journal:  Am J Respir Crit Care Med       Date:  2021-05-01       Impact factor: 21.405

2.  Update in Pediatrics 2020.

Authors:  Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

3.  Fcγ Receptor IIa (FCGR2A) Polymorphism Is Associated With Severe Respiratory Syncytial Virus Disease in Argentinian Infants.

Authors:  María Pía Holgado; Silvina Raiden; Inés Sananez; Vanesa Seery; Leonardo De Lillo; Lucas L Maldonado; Laura Kamenetzky; Jorge Geffner; Lourdes Arruvito
Journal:  Front Cell Infect Microbiol       Date:  2020-12-18       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.